Pregled bibliografske jedinice broj: 1259904
The effect of surgeon’s experience on the outcome of patients with ACC
The effect of surgeon’s experience on the outcome of patients with ACC // 22nd European Congress of Endocrinology
online, 2020. AEP85, 1 doi:10.1530/endoabs.70.aep85 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1259904 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The effect of surgeon’s experience on the outcome of
patients with ACC
Autori
Barac, Anja ; Knezevic, Nikola ; Zibar, Tomsic Karin ; Kastelan, Marko ; Kakarigi, Luka ; Alduk, Ana-Marija ; Matas, Nino ; Balasko, Annemarie ; Kraljevic, Ivana ; Popovac, Hrvoje ; Skoric- Polovina, Tanja ; Solak, Mirsala ; Dusek, Tina ; Kastelan, Darko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Skup
22nd European Congress of Endocrinology
Mjesto i datum
Online, 05.09.2020. - 09.09.2020
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Surgeon’s experience ; Adrenocortical carcinoma
Sažetak
Introduction: Adrenocortical carcinoma (ACC)is a rare disease with an unfavourable prognosis. Complete surgical resection of the tumour provides the only chance for long-term cure. The aim of this study was to compare long term outcomes in patients with ACC referred to surgery in an expert adrenal centre (EC) versus nonspecialised centres (NSC). Materials and methods: This retrospective study included 48 patients with ACC, ENSAT stage I-III. All of study participants underwent complete tumour resection of whom 35 (73%) were operated in a high-volume centre by a dedicated surgeon, whereas 13 (27%) patients were operated in nonspecialised centres. The study analysed the differences between the two groups in terms of recurrence free survival (RFS) and overall survival (OS). Results: Median duration of follow- up was 51 months (5–174) in EC group and 46 months (3–165) in NSC group. Disease recurrence was observed in 5 (14.3%) patients in the EC group and in 5 (38.5%) patients in the NSC group (P = 0.067). Patients in the EC group had longer PFS but the difference did not reached the level of statistical significance (28 (11–45) month vs 19 (3–43) months ; P = 0.083). Overall, seven patients died during follow-up (5 EC, 2 NSC). ACC was the cause of death in two EC patients (5.7%) and in two NSC patients (15.4% ; P = 0.16). Conclusion: The above-mentioned results show thatACC recurrence is less likely to occur in patients operated by a dedicated surgeon in an expert adrenal centre.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Ana Marija Alduk
(autor)
Darko Kaštelan
(autor)
Tina Dušek
(autor)
Nikola Knežević
(autor)
Ivana Kraljević
(autor)